Sanofi: (NYSE: SNY)
$54.56
-0.49 (-0.89%)
Volume 1,182,206
May 23 04:03 PM ET
Zacks Rank: 4-Sell 
| #4 |
Cash flow Statements
Annual Cash Flow Statement
Fiscal Year End for SANOFI-AVENTIS falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
| 12/31/12 | 12/31/11 | 12/31/10 | 12/31/09 | 12/31/08 | |
|---|---|---|---|---|---|
| Cash Flow From Operations, Investments & Financial Activities |
|||||
| Net Income (Loss) | 6,388.05 | 7,929.21 | 7,259.62 | 7,342.56 | 5,664.82 |
| Depreciation/Amortization & Depletion | 6,310.89 | 7,734.21 | 6,810.79 | 6,988.34 | 8,803.93 |
| Net Change from Assets/Liabilities | -426.98 | -717.29 | -367.82 | -1,181.22 | -2,085.87 |
| Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Activities | -1,763.24 | -1,966.63 | -743.62 | -1,274.66 | 154.45 |
| Net Cash From Operating Activities | 10,508.72 | 12,979.50 | 12,958.97 | 11,875.01 | 12,537.33 |
| Property & Equipment | -1,612.76 | -1,981.95 | -1,914.83 | -2,370.82 | -2,181.49 |
| Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | -18,928.15 | -2,301.25 | -7,758.15 | -972.33 |
| Other Investing Activities | -428.27 | 434.55 | -276.20 | -33.47 | -14.71 |
| Net Cash from Investing Activities | -2,041.04 | -20,475.55 | -4,492.28 | -10,162.45 | -3,168.53 |
Uses of Funds
| 12/31/12 | 12/31/11 | 12/31/10 | 12/31/09 | 12/31/08 | |
|---|---|---|---|---|---|
| Cash Flow From Operations, Investments & Financial Activities |
|||||
| Net Income (Loss) | 6,388.05 | 7,929.21 | 7,259.62 | 7,342.56 | 5,664.82 |
| Depreciation/Amortization & Depletion | 6,310.89 | 7,734.21 | 6,810.79 | 6,988.34 | 8,803.93 |
| Net Change from Assets/Liabilities | -426.98 | -717.29 | -367.82 | -1,181.22 | -2,085.87 |
| Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Activities | -1,763.24 | -1,966.63 | -743.62 | -1,274.66 | 154.45 |
| Net Cash From Operating Activities | 10,508.72 | 12,979.50 | 12,958.97 | 11,875.01 | 12,537.33 |
| Property & Equipment | -1,612.76 | -1,981.95 | -1,914.83 | -2,370.82 | -2,181.49 |
| Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | -18,928.15 | -2,301.25 | -7,758.15 | -972.33 |
| Other Investing Activities | -428.27 | 434.55 | -276.20 | -33.47 | -14.71 |
| Net Cash from Investing Activities | -2,041.04 | -20,475.55 | -4,492.28 | -10,162.45 | -3,168.53 |
| Issuance (Repurchase) of Capital Stock | 829.53 | -1,394.19 | -326.66 | 234.29 | -1,729.89 |
| Issuance (Repayment) of Debt | -214.77 | 7,560.11 | -1,959.98 | 3,776.57 | -717.84 |
| Increase (Decrease) Short-Term Debt | -576.17 | -201.95 | 411.64 | -1,094.76 | 819.34 |
| Payment of Dividends & Other Distributions | -4,497.49 | -1,910.92 | -4,157.65 | -4,005.29 | -3,983.46 |
| Other Financing Activities | -1,136.91 | -23.67 | -138.10 | -8.36 | 8.82 |
| Net Cash from Financing Activities | -5,595.82 | 4,029.37 | -6,170.75 | -1,097.55 | -5,603.03 |
| Effect of Exchange Rate Changes | 30.86 | 1.39 | 58.42 | 34.86 | -66.19 |
| Net Change In Cash & Equivalents | 2,902.72 | -3,260.54 | 2,354.36 | 649.88 | 3,699.56 |
| Cash at Beginning of Period | 5,303.87 | 9,004.45 | 6,230.50 | 5,893.57 | 2,516.88 |
| Cash at End of Period | 8,206.60 | 5,743.90 | 8,584.87 | 6,543.46 | 6,216.44 |
| Diluted Net EPS | 2.55 | 2.83 | 2.85 | 2.77 | 2.17 |
